Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | farnesyl diphosphate synthase | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 1.5 ug kg-1 | Effective dose in inhibiting osteoclastic bone resorption | ChEMBL. | 12825934 |
ED50 (functional) | = 1.5 ug kg-1 | Effective dose after subcutaneous administration to TPTX rats for 50% reduction of hypercalcemia | ChEMBL. | 12166945 |
ED50 (functional) | = 1.5 ug kg-1 | Effective dose in inhibiting osteoclastic bone resorption | ChEMBL. | 12825934 |
IC50 (functional) | = -8.41 | Negative logarithm of inhibitory concentration against bone resorption | ChEMBL. | 12825934 |
Log IC50 (functional) | = 8.40500000000002 | Negative logarithm of inhibitory concentration against bone resorption | ChEMBL. | 12825934 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.